Alexandra Snyder
0000-0002-2606-3523
Publication & Citation Trends
Publications
0 total
Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer OA
Cited by 18
Semantic Scholar
Clinical Holds in Early Oncology Drug Development OA
Cited by 0
Semantic Scholar
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma OA
Cited by 73
Semantic Scholar
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy OA
Cited by 140
Semantic Scholar
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma OA
Cited by 32
Semantic Scholar
A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer
Cited by 2
Semantic Scholar
Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer. OA
Cited by 23
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(104)
Immunotherapy and Immune Responses
(44)
Cancer Genomics and Diagnostics
(40)
Ovarian cancer diagnosis and treatment
(32)
Pancreatic and Hepatic Oncology Research
(24)
Affiliations
Inova Health System
University of Southern California
MedStar Washington Hospital Center
Merck & Co., Inc., Rahway, NJ, USA (United States)
Memorial Sloan Kettering Cancer Center